573 related articles for article (PubMed ID: 7810819)
21. Epidemiology of visceral leishmaniasis in India.
Bora D
Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
Thakur CP
Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
[TBL] [Abstract][Full Text] [Related]
23. Kala-azar and post-kala-azar dermal leishmaniasis, Assam, India.
Khan AM; Dutta P; Khan SA; Baruah SK; Raja D; Khound K; Mahanta J
Emerg Infect Dis; 2014 Mar; 20(3):487-9. PubMed ID: 24565057
[No Abstract] [Full Text] [Related]
24. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
Mathur P; Samantaray J; Chauhan NK
Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
[TBL] [Abstract][Full Text] [Related]
25. Kala-azar in Ethopia I: Leishmanin skin test in Setit Humera, a kala-azar endemic area in northwestern Ethopia.
Fuller GK; Lemma A; Haile T; Atwood CL
Ann Trop Med Parasitol; 1976 Jun; 70(2):147-63. PubMed ID: 938122
[TBL] [Abstract][Full Text] [Related]
26. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
Salih MA; Fakiola M; Abdelraheem MH; Younis BM; Musa AM; ElHassan AM; Blackwell JM; Ibrahim ME; Mohamed HS
BMC Infect Dis; 2014 Dec; 14():662. PubMed ID: 25466928
[TBL] [Abstract][Full Text] [Related]
27. The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features.
Musa AM; Khalil EA; Raheem MA; Zijlstra EE; Ibrahim ME; Elhassan IM; Mukhtar MM; El Hassan AM
Ann Trop Med Parasitol; 2002 Dec; 96(8):765-72. PubMed ID: 12625930
[TBL] [Abstract][Full Text] [Related]
28. Leishmanin test survey in an endemic village of Indian kala-azar near Calcutta.
Nandy A; Neogy AB; Chowdhury AB
Ann Trop Med Parasitol; 1987 Dec; 81(6):693-9. PubMed ID: 3503646
[TBL] [Abstract][Full Text] [Related]
29. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
30. High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis.
Gasim S; Theander TG; ElHassan AM
Acta Trop; 2000 Feb; 75(1):35-8. PubMed ID: 10708005
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997).
EL-Safi SH; Bucheton B; Kheir MM; Musa HA; EL-Obaid M; Hammad A; Dessein A
Microbes Infect; 2002 Nov; 4(14):1439-47. PubMed ID: 12475634
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
[TBL] [Abstract][Full Text] [Related]
33. Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north.
el-Hassan AM; Hashim FA; Ali MS; Ghalib HW; Zijlstra EE
Trans R Soc Trop Med Hyg; 1993; 87(4):395-8. PubMed ID: 8249061
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan.
el Hassan AM; Hashim FA; Abdullah M; Zijlstra EE; Ghalib HW
Lepr Rev; 1993 Mar; 64(1):53-9. PubMed ID: 8464317
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes.
Glans H; Dotevall L; Söbirk SK; Färnert A; Bradley M
BMC Infect Dis; 2018 Dec; 18(1):632. PubMed ID: 30526519
[TBL] [Abstract][Full Text] [Related]
36. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
Singh A; Ramesh V; Ramam M
Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
[TBL] [Abstract][Full Text] [Related]
37. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
Mondal D; Nasrin KN; Huda MM; Kabir M; Hossain MS; Kroeger A; Thomas T; Haque R
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957193
[TBL] [Abstract][Full Text] [Related]
38. Post-kala-azar dermal leishmaniasis in the Sudan: peripheral neural involvement.
Elhassan AM; Ali MS; Zijlstra E; Eltoum IA; Ghalib HW; Ahmed HM
Int J Dermatol; 1992 Jun; 31(6):400-3. PubMed ID: 1512091
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases.
Sharma MC; Gupta AK; Verma N; Das VN; Saran R; Kar SK
J Commun Dis; 2000 Mar; 32(1):67-8. PubMed ID: 11129569
[No Abstract] [Full Text] [Related]
40. [Histopathological skin changes after kala-azar: post-kala azar dermal leishmaniasis].
MAJUMDAR TD
Arch Klin Exp Dermatol; 1956; 203(5):483-502. PubMed ID: 13382178
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
